Clinical Trials on Malignant Somatostatinoma

Total 4416 results

University of Southern California
National Cancer Institute (NCI)

Recruiting

18F-FMAU PET/CT in Imaging Patients With Advanced Cancers

Malignant Neoplasm

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Mutations or Fusions (MATCH - Subprotocol K2)

Malignant Solid Neoplasm

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J)

Malignant Solid Neoplasm

United States
The Second Hospital of Lanzhou University

Completed

Comparing 18F-FAPI-04 and 18F-FDG PET/CT in Cancer Detection

Malignant Neoplasm

China
Sameek Roychowdhury

Active, not recruiting

Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.

Malignant Neoplasm

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Terminated

Virtual Reality for the Education of Cancer Patients Undergoing Radiation Therapy

Malignant Neoplasm

United States
Ohio State University Comprehensive Cancer Center

Active, not recruiting

Development of a Digital Tool, MyInspiration, for the Improvement of Spiritual Well-Being in Patients With Cancer

Malignant Solid Neoplasm

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Perioperative Ostomy Self-Management Telehealth for Cancer Patients and Family Caregivers

Malignant Neoplasm

United States
University Hospital, Essen

Completed

FAPI PET/CT Prospective Interobserver Agreement (AGREE-FAPI)

Malignant Neoplasm

Germany
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Trial of SHR-1802 in Patients With Failure of Standard Treatment for Advanced Malignant Tumours

Malignant Tumours

China
Thomas Jefferson University

Completed

Pharmacist-led Transitions of Care in the Outpatient Oncology Infusion Center for Patients With Solid Tumor

Malignant Solid Neoplasm

United States
Lawson Health Research Institute
London Health Sciences Centre

Completed

Can Electronic Information Kiosks Enhance Patient Accrual for Cancer Clinical Trials? A Pilot and Feasibility Study

Malignant Neoplasm

Canada
SynCore Biotechnology Co., Ltd.

No longer available

Long-Term Compassionate Use Study for Continued Administration of SCB01A-01

Malignant Solid Tumour
Assiut University

Unknown

us Elastography and us Doppler in Differentiating Breast Masses

Breast Lump (Malignant)
Vanderbilt-Ingram Cancer Center

Terminated

Yoga Intervention in Supporting Children With Cancer and Their Parents During Chemotherapy Infusion

Malignant Neoplasm

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Local Anesthetic Cream in Younger Patients Undergoing Lumbar Punctures

Malignant Neoplasm

United States
Yonsei University

Unknown

Efficacy of Partial Covered Double Bare Metal Stent Compared to Uncovered Double Bare Metal Stent in Malignant Biliary Obstruction

Malignant Tumor

Korea, Republic of
Seoul National University Hospital
Taewoong Medical Co., Ltd.

Unknown

Metal Versus Plastic Stent in Malignant Hilar Biliary Obstruction

Malignant Hepatobiliary Neoplasm

Korea, Republic of
Sanofi

Completed

A Study of SAR428926 in Patients With Advanced Solid Tumors

Neoplasm Malignant

France, Denmark, Spain
Sanofi

Completed

Phase 1 Safety Testing of SAR405838

Neoplasm Malignant

United States, France, Netherlands
Assiut University

Unknown

Endoscopic Ultrasonography Guided Biliary Drainage

Malignant Hepatobiliary Neoplasm
National Cancer Institute (NCI)

Completed

Evaluation of Food Effect on Pharmacokinetics of Vismodegib

Malignant Neoplasm

United States
Tianjin Medical University Cancer Institute and...

Unknown

Clinical Trial of Bile Etiology ,Proteomics and Metabonomics of Malignant Biliary Obstruction (MBO-IR)

Malignant Biliary Obstruction

China
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Tailoring Patient Education to Perceived Risk for Falls in Hospitalized Oncology Patients

Malignant Neoplasm

United States
Sanofi

Completed

Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid Tumors

Neoplasm Malignant

Japan
Sanofi

Completed

A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors

Neoplasm Malignant

United States
Ohio State University Comprehensive Cancer Center

Completed

Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC)

Malignant Neoplasm

United States
Sanofi

Completed

A Study to Investigate the Disposition of Radio-labeled AVE8062 Compound Administered as a 30-minute IV Infusion to Patients With Advanced Solid Tumor

Neoplasms, Malignant

Belgium
Sanofi

Completed

Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Cisplatin in Patients With Solid Tumors

Neoplasms, Malignant

Japan
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Sapanisertib, Carboplatin, and Paclitaxel in Treating Patients With Recurrent or Refractory Malignant Solid Tumors

Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Dual Energy Computed Tomography (CT) in Finding Bone Metastases in Patients With Cancer

Malignant Neoplasm | Metastatic Malignant Neoplasm to the Bone

United States
National Cancer Institute (NCI)

Terminated

EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer

Primary Peritoneal Cavity Cancer | Malignant Ascites | Recurrent Malignant Mesothelioma | Advanced Malignant Mesothelioma | Localized Malignant Mesothelioma

United States
Cancer Research UK
Royal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of Birmingham

Recruiting

DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers. (DETERMINE)

Glioma | Melanoma | Neoplasms by Histologic Type | Lymphoproliferative Disorders | Neoplasms by Site | Cancer | Brain Neoplasms | Solid Tumor | Malignant Neoplasm | Malignancy | Haematological Malignancy

United Kingdom
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Recruiting

Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)

Malignant Solid Neoplasm

United States
New Mexico Cancer Care Alliance
National Cancer Institute (NCI)

Recruiting

Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing (PE-CGS)

Malignant Neoplasm

United States
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

NV-001 in the Treatment of Advanced Solid Tumors

Malignant Neoplasm

China
Nanjing Leads Biolabs Co.,Ltd

Recruiting

A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors

Malignant Tumors

China
Chinese University of Hong Kong

Recruiting

EUS-guided Hepatico-gastrostomy Using a Novel Lumen Apposing Metal Stent

Malignant Biliary Obstruction

Hong Kong
University Hospitals Dorset NHS Foundation Trust
The Christie NHS Foundation Trust

Recruiting

The ID- RFA Trial: A Trial of Intraductal Radio-frequency Ablation (ID-RFA) Plus Biliary Stenting Versus Biliary Stenting Alone for the Treatment of Malignant Biliary Obstruction.

Malignant Biliary Obstruction

United Kingdom
University Hospital, Essen

Recruiting

FAPI-PET for Tumor Detection

Malignant Neoplasm

Germany
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Molecular Genetics Studies of Cancer Patients and Their Relatives

Malignant Neoplasm

United States, Peru, Colombia, Mexico, Puerto Rico
Memorial Sloan Kettering Cancer Center

Recruiting

Characterization of Hyperpolarized Pyruvate MRI Reproducibility

Malignant Solid Tumors

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G)

Malignant Solid Neoplasm

United States
Wake Forest University Health Sciences

Terminated

Developing and Validating Fertilit-e

Malignant Neoplasm

United States
University of Utah

Terminated

Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors

Malignant Neoplasm

United States
Sanofi

Active, not recruiting

Evaluation of SAR408701 in Patients With Advanced Solid Tumors

Neoplasm Malignant

United States, Canada, France, Korea, Republic of, Spain
Jiangsu HengRui Medicine Co., Ltd.

Completed

Effect of Omeprazole on Pharmacokinetics of SHR2554 in Healthy Subjects

Malignant Tumor

China
LaNova Medicines Limited

Suspended

A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors

Malignant Tumors

China
Tianjin Chasesun Pharmaceutical Co., LTD

Enrolling by invitation

A Study of IMMH-010 in Patients With Advanced Malignant Solid Tumors

Malignant Neoplasms

China
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Music Therapy Video Development in Improving Communication, Emotional Distress, and Recovery in Adolescents/Young Adults Undergoing Treatment for High-Risk Cancer and Their Parents

Malignant Neoplasm

United States

Clinical Trials on Malignant Somatostatinoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations